Department of Biology, McGill University, Montreal, Quebec, Canada
SUMMARY INTRODUCTION COMPONENTS AND SYNTHESIS ß-1,3-Glucan Glucan synthase. (i) Catalytic subunit: the FKS family. (ii) Rho1, a regulatory subunit. (iii) Fungal glucan synthases. ß-1,6-Glucan Genetic analysis. (i) KRE5. (ii) BIG1 and ROT1. (iii) KRE6 and SKN1. (iv) KRE1. (v) KRE9 and KNH1. (vi) Overview. Chitin and Chitosan Chitin synthase. Chitin deacetylases. Mannoproteins Protein glycosylation and mannan synthesis. (i) Protein N glycosylation. (ii) Protein O mannosylation. GPI-cell wall proteins. The PIR family and mild-alkali-extractable cell wall proteins. (i) The PIR family. (ii) Other cell wall proteins with alkali-sensitive links. Roles of cell wall mannoproteins. Cell Wall-Remodeling Enzymes Glucan-remodeling enzymes. (i) GAS1 and the GAS gene family. (ii) Glucanases and glucanase-related proteins. (iii) Fungal remodeling enzymes. Chitinases. Glucan/chitin-cross-linking enzymes. CELL WALL BIOLOGY AS AN INTEGRATED PROCESS Regulation Occurs at Multiple Levels Cell cycle. Cell polarity and isotropic/apical growth. Mating, pseudohyphal growth, and sporulation. Adaptation to external conditions. (i) The PKC cell integrity pathway. (ii) Other regulatory pathways. Towards an Integrative Analysis CONCLUSION ACKNOWLEDGMENTS REFERENCES
| SUMMARY |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
This review primarily covers work on the cell wall of the yeast Saccharomyces cerevisiae but, when appropriate, draws on studies of other fungi for comparison. A powerful attraction of S. cerevisiae is that the whole organism is under intensive study, providing information on all aspects of its biology as they relate to the cell wall. While an in-depth study of the structure and function of the cell wall of one species is critical, fungal cell walls are highly diverse, so yeast studies will capture only a fraction of the fungal cell wall repertoire.
| COMPONENTS AND SYNTHESIS |
|---|
|
|
|---|
30% of the dry weight of the cell and is composed largely of polysaccharides (
85%) and proteins (
15%) (206). Extensive biochemical analyses reveal that glucose, N-acetylglucosamine (GlcNAc), and mannose residues represent 80 to 90%, 1 to 2%, and 10 to 20% of the total polysaccharide, respectively. Glucose residues are linked to other glucose molecules through ß-1,3 and ß-1,6 linkages and to GlcNAc via ß-1,4 bonds. Mannoproteins can be linked to ß-1,6-glucose chains through a processed glycosylphosphatidylinositol (GPI) anchor or to ß-1,3-glucan through an alkali-labile bond (see references 73, 130, 136-138, and 194 and references therein). Based on these analyses, a structure for the mature cell wall has been proposed (36, 73, 136, 256) and is illustrated in Fig. 1A. Chains of ß-1,3-linked glucose residues are branched by ß-1,6 linkages, forming a fibrillar ß-1,3-glucan which serves as a backbone to which are linked chitin, ß-1,6-glucan, and some mannoproteins. In addition, the ß-1,6-glucan and GPI mannoproteins are linked together via a remnant of their GPI anchors. The vegetative cell wall has a layered ultrastructure as observed by electron microscopy (212), with an inner layer of glucans and chitin and an outer layer of mannoproteins.
|
During sporulation of diploid cells, meiotic ascospores are encapsulated in the ascus by a specialized cell wall, the ascospore wall (51, 264) (Fig. 1C). The ascospores are connected by chitosan-containing structures, the interspore bridges (54). The ascospore wall, which is more robust than the vegetative cell wall, has a multilayered structure. ß-Glucans and mannoproteins form the innermost layer, which is surrounded by fibrils of chitosan, a deacetylated chitin polymer. The outermost layer is composed of dityrosine, an insoluble arrangement of cross-linked D- and L-tyrosine residues.
1,500 glucose units/chain, have a coiled spring-like structure that confers elasticity and tensile strength to the cell wall (136, 137). In cell wall extracts, ß-1,3-glucan is found as a branched polymer with ß-1,6 interchain links. ß-1,3-Glucan is covalently linked to the other wall components (Fig. 1A): its nonreducing ends are cross-linked to the reducing ends of chitin chains through a ß-1,4 link; ß-1,6- and ß-1,3-glucan chains are attached by a still-uncharacterized link. Some O-mannosylated cell wall proteins (CWPs) are attached to ß-1,3-glucan via an alkali-sensitive bond (73, 136-138, 194). Glucan synthase. ß-1,3-Glucan synthase (ß-1,3-GS) (Table 1) subunits have been identified using an in vitro assay for ß-1,3-GS activity. Basically, membrane extracts are incubated with radiolabeled UDP-glucose in the presence of GTP, and the accumulation of acid-insoluble radioactive ß-1,3-glucan follows (35). By using such an assay, ß-1,3-GS was separated into membrane-bound and cytosolic fractions, containing catalytic and regulatory GTP-binding subunits, respectively (127). Cytoplasmic UDP-glucose is likely the in vivo sugar donor, since mutants with defects in UDP-glucose synthesis show cell wall defects (210).
|
FKS1 (for FK506 sensitive) was originally cloned by complementation of a mutant that was hypersensitive to the calcineurin inhibitor FK506 (216). The link between FKS1 and the cell wall was established by the finding that ETG1 and PBR1 (whose mutants are resistant to ß-1,3-GS inhibitors), CWH53 (required for resistance to calcofluor white), and CND1 (with mutant alleles requiring a functional calcineurin pathway) are all identical to FKS1 (44, 76, 80, 91, 231). FKS1 mutants show decreased ß-1,3-GS activity, while Fks1 cofractionates with GS activity, implicating Fks1 as a ß-1,3-GS catalytic subunit (76, 119). FKS1 encodes a 1,876-amino-acid (aa) protein which localizes at the plasma membrane and is predicted to have 16 transmembrane domains (TMDs) (76, 119, 228). An Fks1-green fluorescent protein (GFP) fusion protein expressed from the FKS1 promoter localizes to sites of polarized growth and colocalizes dynamically with actin patches (71, 286). Fks1 shows a four-domain structure: it includes an
400-aa N-terminal cytosolic tail thought to be involved in activation of the GS activity, an
300-aa region containing six TMDs and required for Fks1 localization to sites of polarized growth, an
600-aa cytosolic putative catalytic domain, and a C-terminal
600-aa domain containing 10 TMDs and involved in localization to the cell surface (71).
GSC2 encodes a 1,895-residue protein that is 88% identical to Fks1 and has a similar topology and domain organization. As with Fks1, a GFP-Gsc2 fusion protein is localized to the sites of polarized growth (71). Gsc2 and Fks1 form a redundant essential pair, with a double fks1
gsc2
mutant being unviable (119. 178). This synthetic lethality and the finding that purified membranes from an fks1
mutant, which express only Gsc2, show ß-1,3-GS activity which can be immunodepleted on treatment with anti-Gsc2 antibodies (119, 178) indicate that Gsc2 is involved in ß-1,3-glucan synthesis.
FKS1 and GSC2 show differential patterns of expression. The FKS1 gene is expressed during mitotic growth, consistent with its proposed function as the major ß-1,3-GS subunit. Upon
-factor release of a synchronized population, levels of the FKS1 transcript peak at the late G1/S phase of the cell cycle, in a way similar to that for the G1/S cyclin CLN2, thymidylate synthase CDC21, and histone H2A HTA2 transcripts (178, 231). This expression pattern is dependent on Swi4, the DNA-binding component of the Swi4-Swi6 cell cycle box binding factor (SBF) transcription factor (115). A genome-wide survey of SBF binding sites by chromatin immunoprecipitation followed by microarray hybridization revealed that the FKS1 promoter is bound in vivo by SBF (121). These data indicate that during the cell cycle, FKS1 expression is regulated by the SBF transcription factor. In addition, a weak Rlm1-dependent increase of FKS1 mRNA levels upon hyperactivation of the mitogen-activated protein (MAP) kinase Slt2 has been reported (123), suggesting that the protein kinase C (PKC) cell integrity pathway through its principal transcription factor Rlm1 also regulates FKS1 expression.
In contrast, GSC2 mRNA, which is undetectable during mitotic growth on glucose, accumulates upon glucose exhaustion, during growth on low levels of glucose, or during growth on galactose, glycerol, or acetate. These expression changes coincide with decreased levels of the FKS1 transcript (178, 313). Thus, GSC2 expression appears to be under catabolite repression. Consistent with this, deletion of the catabolic-repressor-encoding gene MIG1 results in a high basal transcription and a weak low-glucose induction of a GSC2-driven reporter. Further, the induction of GSC2 at low glucose concentrations is regulated by the Snf1 protein kinase, mediating derepression of glucose-repressed genes (313). The regulators of GSC2 induction upon entry into stationary phase and on nonglucose substrates have not been identified. Whether GSC2 transcript levels are cell cycle regulated during growth on a nonglucose carbon source is unknown.
GSC2 can also be induced by a number of environmental stimuli. The addition of extracellular calcium or
-factor leads to strong GSC2 induction that is dependent on the calcineurin signaling pathway (178) and is mediated by Crz1, a zinc finger transcription factor that binds to a calcineurin-dependent response element in the GSC2 promoter (176, 268).
Shift of a wild-type strain from 23°C to 39°C also induces GSC2 mRNA accumulation (313). A block in the calcineurin pathway by addition of the drug FK506 delays this induction, indicating that the calcineurin pathway is responsible for the rapid GSC2 response upon heat shock. In contrast, an slt2 mutant, which is defective in PKC cell integrity pathway signaling, exhibits a rapid but transient increase of GSC2 mRNA levels upon temperature shift, suggesting that the PKC cell integrity pathway is required for the maintenance of GSC2 expression during growth at high temperature (313). Further, exposure to cell wall- and cell surface-damaging agents, such as caspofungin and amphotericin B, or deletion of genes required for cell wall assembly, such as fks1, gas1, kre6, mnn9, or smi1, also results in high levels of GSC2 mRNA (5, 145, 178, 232). These effects, too, are thought to be mediated by the PKC cell integrity and/or the calcineurin pathway (see below). For example, exposure of wild-type cells to calcofluor white (a toxic chitin-binding agent) or to Zymolyase (a ß-1,3-glucanase enzymatic preparation) increases expression of a GSC2-lacZ reporter in an Slt2-dependent manner (68). A promoter dissection study revealed that both Rlm1, the target of the PKC cell integrity pathway, and Crz1 mediate calcofluor induction of a GSC2-lacZ reporter (145). Finally, treatment with the reducing agent dithiothreitol induced high levels of the GSC2 transcript (282). Possible explanations for this include cell wall stress caused by perturbing the function of disulfide-bridged cell wall proteins, Fks1 misfolding, or a disruption of intracellular calcium homeostasis caused by malfunction of the endoplasmic reticulum (ER).
Consistent with Fks1 function in ß-1,3-glucan synthesis, an fks1
mutant shows a reduced ß-1,3-GS activity and an altered cell wall composition, with decreased ß-1,3- and ß-1,6-glucan levels and increased chitin and mannan levels (30, 59, 71, 76, 151, 213, 232). In contrast, during vegetative growth on glucose, a gsc2 mutant has no cell wall defect or growth phenotype. However, a homozygous gsc2/gsc2 null diploid fails to sporulate. The effects of the deletion of FKS1 or GSC2 can be partially suppressed by overexpression of the other member of the pair (71, 178), indicating their functional similarity. However, the strength of the phenotypes observed in an fks1 mutant compared to a gsc2 mutant shows that Fks1 is the major player during vegetative growth on rich medium, with Gsc2 being the protein functioning under more stressful conditions. As mentioned above, fks1 mutants show hypersensitivity to FK506 or calcofluor white (91, 231), two phenotypes explained by the calcineurin-dependent GSC2 induction and by the increased cell wall chitin found in the fks1 mutant. Interestingly, an fks1
mutant is more sensitive to caspofungin, echinocandins, or aerothricin 3 than is a gsc2
mutant (139, 150, 178). The differential sensitivity of the two proteins to these compounds and their expression balance likely explain these phenotypes.
The S. cerevisiae FKS family has a third member, FKS3, whose product is 55% identical to both Fks1 and Gsc2. A search for Fks3 function in glucan or cell wall synthesis under vegetative growth conditions has been unsuccessful: no phenotype was associated with an FKS3 deletion, and no activity could be attributed to Fks3 (71). However, in a large-scale search for sporulation mutants, a homozygous fks3/fks3 null diploid was found to be sporulation deficient, indicating that Fks3 is required for optimal sporulation (70). FKS3 expression is regulated by Ste12 upon pheromone exposure (311), implying that Fks3 may also have some role in mating.
(ii) Rho1, a regulatory subunit. Considerable biochemical and genetic evidence identifies the Rho1 GTPase as a regulator of ß-1,3-GS (78, 177, 228): (i) Rho1 colocalizes and copurifies with Fks1 and cofractionates with ß-1,3-GS activity, (ii) a thermosensitive rho1 mutation leads to thermolabile ß-1,3-GS activity, and (iii) a hyperactive rho1 allele shows a GTP-independent ß-1,3-GS activity. The essential 24-kDa Rho1 is the prototype of small G proteins which in their active GTP-bound state bind and activate their effectors (for reviews, see references 34 and 274). Although Fks1 and Gsc2 are well established as Rho1 effectors, the interaction domains between the catalytic and the regulatory subunits of the ß-1,3-GS and the basis for Rho1 activation on ß-1,3-GS catalytic subunits remain unknown. In addition to its role as a subunit of the ß-1,3-GS, Rho1 plays a critical role in the coordination of cell wall organization and the polarization of the actin cytoskeleton by regulating signaling through the cell integrity pathway (see "The PKC cell integrity pathway" below and Fig. 4). These Rho1 functions are separable, and a phenotypic and complementation analysis of 12 rho1 temperature-sensitive alleles identified 4 rho1 alleles with direct effects on ß-1,3-GS activity (245). The Cabib group reported seven additional temperature-sensitive rho1 alleles specifically affecting ß-1,3-GS regulation (239). These showed bud lysis and decreased incorporation of cell wall component phenotypes at the restrictive temperature.
|
double mutant, which shows a thermolabile ß-1,3-GS activity (253), Oyha's group reported that mutation in LRG1 or overexpression of ROM2 restored the impaired ß-1,3-glucan synthesis of this mutant (253, 301). Two additional multicopy suppressors of the fks1-1154 gsc2
phenotype, LRE1 and ZDS1, activate the GS activity through Rho1 (253). However, no GEF activity has been described for the products of these two genes, and how they act to stimulate ß-1,3-glucan synthesis is still unclear. Finally, Rho1 is membrane anchored via a C-terminal prenylyl tail, which is required for Rho1 membrane association and for its function in regulating ß-1,3-GS activity (118).
(iii) Fungal glucan synthases. ß-1,3-Glucan is widely used by fungi, and a BLAST search for Fks1 homologues in the NCBI nonredundant database of fungal protein sequences on 1 February 2006 returned over 90 matches with E values of <0.001 in 40 organisms (http://www.ncbi.nlm.nih.gov/BLAST/). Yarrowia lipolytica, Cryptococcus neoformans, Coccidiodes posadasii, and Pneumocystis carinii all possess a single essential FKS gene (132, 149, 218, 278). A single FKS orthologue is also found in the completed genomes of Aspergillus nidulans, Aspergillus fumigatus, Neurospora crassa, and Rhizopus oryzae, indicating that these organisms also possess a single FKS gene that is likely essential (17, 114, 133, 249). The FKS protein of N. crassa bound the UDP-glucose analog 5-azido-UDP-glucose in a cross-linking study using a partially purified FKS preparation (249). However, work is needed to confirm the specificity and functional relevance of this substrate binding. The genome of Candida albicans contains three putative FKS homologues. Of these, the GSC1 gene is essential, and mutant alleles show an altered sensitivity to echinocandins; in contrast, GSL1 encodes a truncated protein, and GSL2 expression, if any, is very low (183). Thus, it is likely that a single and essential catalytic GS subunit, encoded by GSC1, functions in this organism. Finally, some species, such as Schizosaccharomyces pombe, Ashbya gossypii, and members of the genus Saccharomyces, have an FKS gene family. For example, Schizosaccharomyces pombe has four FKS homologues, three of which (bsg+, bsg2+, and bsg3+) are expressed during vegetative growth and sporulation and one of which (bsg4+) is sporulation specific. The differential localization of these proteins indicates that each has a specialized function in polarized cell wall growth, septum synthesis and cytokinesis, and ascospore wall assembly (56, 57, 158, 173, 174). This presence of an FKS family in some organisms probably reflects the selective retention of duplicated genes through increased fitness conferred by their specialized application of GS function. This complexity is also found in plants, the cell walls of which can contain callose, a ß-1,3-glucan induced in response to wounding. Plant cells possess multiple FKS genes, with many of the 12 callose synthase genes present in the genome of Arabidopsis thaliana being tissue and development specific (for a review, see reference 292).
The absence of ß-1,3-glucan in mammals and its widespread distribution and essentiality in the fungal kingdom has made GS a favored antifungal target. Echinocandins, such as caspofungin, have been developed as drugs targeting GS. Caspofungin is active against many Candida and Aspergillus species and is approved for the treatment of fungal infections in patients whose infections are refractory to other therapies (for a review, see reference 69). Despite the ß-1,3-GS activity from Cryptococcus neoformans membranes being effectively inhibited in vitro, Cryptococcus neoformans is resistant to caspofungin (169). However, in Cryptococcus neoformans, caspofungin has been found to be synergistic in combination with membrane-interfering drugs such as amphotericin B or azoles (88).
350 glucose residues (138), with the ß-1,6 backbone branched with ß-1,6 side chains via 3,6-substituted glucose residues on
15% of the residues (167, 170). In vegetative cells, the ß-1,6-polymer comprises
12% of the cell wall polysaccharide (167).
Data from C. albicans show that its ß-1,6-glucan polymer has a more linear structure than that found in S. cerevisiae, with branch points on
7% of the residues, and is more abundant, comprising
21% of the total cell wall carbohydrate (108, 184). Recent structural studies on the cell wall of Schizosaccharomyces pombe clarify the nature and structure of its ß-1,6 polymer (168, 271), now called diglucan by Magnelli et al. (168). Diglucan has a ß-1,6-linked backbone, but 75% of these residues are also ß-1,3 linked so that the polymer is highly branched, far more so than in S. cerevisiae and C. albicans. Schizosaccharomyces pombe diglucan is moderately abundant, comprising 15% of the cell wall polysaccharide.
These comparative studies indicate the variability of ß-1,6-glucan structure among yeasts, with the more highly branched Schizosaccharomyces pombe diglucan likely a variant of the ß-1,6-glucan found in S. cerevisiae and C. albicans. A simplifying general view is that these polymers share a common path of synthesis of the ß-1,6 backbone, with much fungus-specific variation in frequency of branching and cross-linking. If this common-pathway view is true, then the immunodetection of a ß-1,6-polymer in the Golgi and vesicles of Schizosaccharomyces pombe (113) shows that synthesis of the ß-1,6 backbone occurs at least partially in the secretory pathway. However, Magnelli et al. (168) point out that the diglucan structure also raises the possibility of a synthesis from preformed building blocks, for example, from repetitive core units that are linked to each other from a lipid-linked oligosaccharide or by a transglycosidase.
The ß-1,6 polymer has been reported to occur widely among the fungi, including the Hemi-, Archae-, and Euascomycetes and the Basidiomycetes (see discussion in reference 297). An analysis of the alkali-insoluble fraction of the cell wall of the filamentous euascomycete A. fumigatus found no ß-1,6-glucan (87). However, there are reports of wall proteins covalently linked to ß-1,6-glucan in the related species Aspergillus niger and Fusarium oxysporum (26, 252). Thus, a comparative structural analysis of the cell walls of filamentous ascomycetes for the presence of ß-1,6-glucan is needed among this large and divergent group of fungi. More generally, the widespread occurrence of the polymer across fungal lineages shows that it was present early in fungal evolution prior to the Basidiomycetes-Ascomycetes divergence and that it may have subsequently been lost from some groups.
Genetic analysis. Extracellular polysaccharides are made either in secretory pathway compartments (e.g., N- and O-glycans) or at the cell surface (e.g., ß-1,3-glucan and chitin). While it remains unclear which synthetic pathway is used to make ß-1,6-glucan, components both in the secretory pathway and at the cell surface are required.
In S. cerevisiae, genes affecting ß-1,6-glucan levels are found throughout the secretory pathway to the cell wall (213, 256), and it has been proposed that these define a biosynthetic pathway (21, 210). However, most of these genes are not directly involved in ß-1,6-glucan synthesis, and this has prevented identification of the gene(s) encoding the ß-1,6-glucan synthase. On the more positive side, ß-1,6-glucan genetics have uncovered much interactional complexity of cell surface assembly in which the synthesis and regulation of this polymer are embedded (Table 1).
For example, a cluster of genes involved in protein glucosylation-dependent ER quality control in other organisms (KRE5, CNE1, CWH41, and ROT2, encoding UDP-glucose:glycoprotein glucosyltransferase [UGGT]- and calnexin-related proteins and glucosidases I and II, respectively) are required for normal levels of ß-1,6-glucan synthesis in S. cerevisiae (2, 256, 257). Why this is so is unknown, but they likely act indirectly to maintain wild-type levels of some unidentified components of the ß-1,6-glucan synthetic machinery. Such a situation resembles the finding for Arabidopsis thaliana that glucosidases I and II, the plant equivalents of S. cerevisiae Cwh41 and Rot2, are required for cellulose synthesis (32, 96). Further, in S. cerevisiae, a cluster of genes involved in core N-glycan synthesis also affects ß-glucan levels (45, 213, 257). Possible explanations include the synthetic components being N-glycoproteins or the need for a glucosylated acceptor structure for ß-1,6-glucan chain initiation.
(i) KRE5. One gene, KRE5, which has quality control functions in other organisms but a strong ß-1,6-glucan phenotype in S. cerevisiae, has been particularly intensively studied. Kre5 is a large soluble ER-resident protein (153, 180) that shows weak but significant sequence similarity to eukaryotic UGGTs and is a highly diverged member of this family (10). Classic UGGTs monoglucosylate misfolded N-glycoproteins in the ER as part of a protein-refolding pathway (reviewed in reference 217). This pathway has not been found to operate in S. cerevisiae; rather, mutations in KRE5 are lethal or cause very severe growth defects and greatly reduced levels of ß-1,6-glucan (11, 153, 180).
Comparative studies strongly suggest that the S. cerevisiae Kre5 is a diverged UGGT and that the role of KRE5 in ß-1,6-glucan synthesis is indirect. The C. albicans Kre5 sequence far more closely resembles the well-characterized UGGTs (108) and, although this has not been shown directly, is likely a UGGT. C. albicans homozygous kre5/kre5 null mutants are viable and show reduced ß-1,6-glucan levels, though the residual 20% of the polymer in the mutant appears identical in structure to that of the wild type. This glucan phenotype argues that Kre5 is not the C. albicans ß-1,6-glucan synthase. The C. albicans KRE5 gene complements an S. cerevisiae kre5 null mutant (108, 153) and allows ß-1,6-glucan levels to be restored (108). Thus, as the C. albicans protein can substitute for the S. cerevisiae one, the S. cerevisiae Kre5p is also likely to be a UGGT. Both Levinson et al. (153) and Herrero et al. (108) speculate that the diverged S. cerevisiae protein is a more specialized UGGT in these yeasts, perhaps serving as an ER protein glucosyltransferase/chaperone dedicated to proteins involved in ß-1,6-glucan synthesis.
(ii) BIG1 and ROT1. BIG1 and ROT1 are fungus-specific essential genes whose null mutants can be osmotically rescued by adding 0.6 M sorbitol to the growth medium to give very slowly growing cells that, with patience, are amenable to experimentation. Both genes were initially identified as suppressors of target of rapamycin-related phenotypes by the Hall group (18). Consistent with their invoking a cell wall stress response, both big1 and rot1 mutants have increased ß-1,3-glucan and chitin levels (18, 165, 213). Mutants with mutations in BIG1 and ROT1 have large reductions in ß-1,6-glucan compared to a wild-type strain, though, importantly, there is a small amount of residual polymer, suggesting that, like KRE5, neither gene encodes the ß-1,6-glucan synthase. Both Big1 and Rot1 are small integral membrane proteins. Big1 is an ER resident, while the location of Rot1 is unknown. A big1 mutant synthetically interacts with a kre5 mutant but not with a rot1 mutant, implying that Big1 and Rot1 act in a related pathway, perhaps in protein folding or quality control, that is at least partially distinct from that of Kre5 in the ER.
(iii) KRE6 and SKN1. The duplicated pair of type 2 Golgi proteins encoded by KRE6 and SKN1 is required for normal levels of ß-1,6-glucan. Both proteins have a luminal domain with sequence and structural similarity to family 16 glycoside hydrolases, which are likely glucosyl hydrolases or transglucosylases (186). Such an activity might indicate some glucose-processing step, rather than a glucan synthase. Possibilities include processing of some precursor or acceptor for ß-1,6-glucan polymer synthesis or the processing of a ß-1,6-glucan synthase-associated glycoprotein.
(iv) KRE1. KRE1 is linked biosynthetically with ß-1,6-glucan. The kre1 mutant has both a reduced level and an altered structure of the residual polymer, with the mutant polymer being shorter than the wild type (21). This suggests that the plasma membrane-associated, GPI-anchored Kre1 acts to extend the chain by adding linear ß-1,6-glucan onto a highly branched acceptor glucan.
(v) KRE9 and KNH1. The duplicated pair of fungus-specific genes KRE9 and KNH1 is synthetically lethal and shows a strong ß-1,6-glucan reduction, with a kre9 null mutant having shorter ß-1,6-glucan chains as shown by gel filtration (25, 256). They likely encode secreted or cell surface O-glycoproteins, but this has been shown only by their overexpression (72). Possible roles for these proteins include anchoring or cross-linking the newly synthesized ß-1,6-glucan in the wall or as extracellular components of a ß-1,6-glucan synthase.
(vi) Overview. Why has genetic analysis been so difficult here? Potential problems hindering gene identification are that the ß-1,6-glucan synthase may have an essential gene for which hypomorphic alleles are difficult to obtain or that these synthases form a gene family where mutants with mutations in single genes have weak phenotypes. Further, the area lacks any complementary biochemistry. To begin biochemical approaches, a sensitive dot blot immunoassay for the in vitro synthesis of ß-1,6-glucan has been developed using an anti-ß-1,6-glucan specific antibody (297). This assay requires a crude cell-free membrane preparation, UDP-glucose, and GTP. The nature of the in vitro reaction has not been investigated, but in defective mutants the rate of de novo synthesis correlates with their reduced levels of endogenous ß-1,6-glucan. This suggests that ß-1,6 chain elongation is being measured, with the rate of the in vitro reaction being proportional to the number of ß-1,6-glucan chains present at the start of the reaction in the membrane extracts of the various mutants. The GTP dependence of the reaction implies involvement of a GTP-binding protein in regulating ß-1,6-glucan synthesis. The reaction was independent of RHO2 to -5 but was stimulated by overexpression of RHO1, suggesting that like ß-1,3-glucan synthase, ß-1,6-glucan synthase is Rho1 dependent. It is hoped that this assay will be the spur for some much-needed biochemical investigation in this area.
100 and 190 GlcNAc residues, respectively (128, 136). In the cell wall, about 40 to 50% of the chitin chains are linked to the nonreducing end of ß-1,3-glucan via a ß-1,4 bond engaging the reducing end of the chitin polymer (137) (Fig. 1A). Its crystalline structure confers stretching resistance to the cell wall. Chitin deposition within the cell is precisely controlled both spatially and temporally (for a review, see reference 29). At late G1, it is deposited as a ring at the site of bud emergence, then as a disk (the primary septum), and finally in the lateral cell wall of the mother cell after septation (Fig. 1B and 2).
|
A C-terminally tagged Chs2 can be detected throughout the secretory pathway in cells that are unbudded or have a small bud, while it is found at the bud neck in large-budded cells (Fig. 2A), indicating that Chs2 localization is regulated during the cell cycle. Analyses of
-factor-synchronized cells show that the levels of CHS2 mRNA and Chs2 fluctuate with the cell cycle, peaking during M phase and at the end of mitosis, respectively, while pulse-chase analysis indicates that Chs2 is synthesized only at the end of mitosis (50, 215, 267). Chs2 levels are stabilized by sec1-1, sla2/end4-1, and pep4
mutations, affecting Golgi-plasma membrane transport, endocytosis, and protein degradation in the vacuole, respectively. Collectively, these results indicate that Chs2 is transported through the secretory pathway to the plasma membrane at the bud neck, internalized by endocytosis, and then targeted to the vacuole for degradation (50) (Fig. 2A). CHS2 is essential in many strain backgrounds, and chs2 mutants show major septum disorganization, indicating that Chs2 makes the chitin in the primary septum (258, 261). In addition to Chs2, the process of septation requires an actin-myosin ring, which provides the contractile force required for cytokinesis and whose function is intimately linked to that of Chs2 (251). The localization of both Chs2 and the actin-myosin ring requires the assembly of 10-nm septin filaments consisting of five conserved GTP-binding domain-containing proteins (the CDC3, -10, -11, and -12 and SHS1/SEP7 gene products) (see references 77, 160, and 294 for reviews on septin function and assembly). Septin filaments organize as a ring that forms prior to bud formation at the incipient bud site and acts as a scaffold recruiting proteins to the bud neck, including actin-myosin ring components, such as Myo1 and filamentous actin (157; see references 77, 160, and 294 for reviews). At the start of cytokinesis, the septin ring splits into two rings which act to restrict Chs2 localization, thus guiding septum synthesis between the split rings (74, 240). This process is illustrated in Fig. 2A. In septin mutants, localization of Chs2 and other components of the septation apparatus is perturbed, leading to ectopic septum synthesis (240).
Exit of Chs3 from the ER and its further transport to the Golgi requires Chs7, which prevents Chs3 aggregation (140, 284). Examination of Chs3 localization by indirect immunofluorescence reveals intracellular and punctuate labeling in most cells, with a ring structure at the bud neck of small-budded cells (50) (see Fig. 2B for a cartoon of Chs3 trafficking dynamics). Though the levels of CHS3 mRNA fluctuate during the cell cycle, with a peak in G1 (215), the steady-state levels of Chs3 are stable, with a half-life of 90 min, and are unaffected by deletion of PEP4, indicating that Chs3 is not degraded in the vacuole (50). Rather, a large fraction of the protein accumulates in intracellular vesicles, loosely termed chitosomes, with a minor fraction found at the plasma membrane (50, 315). The intracellular transit of Chs3 has been elucidated using mutants with secretory defects. A sec1-1 mutant accumulates Chs3 in Golgi-derived vesicles (50), whereas a chs5
mutant accumulates Chs3 in an inactive form in Golgi-derived vesicles (47, 247). In a chs6 null mutant, Chs3 accumulates in chitosomes and does not reach the plasma membrane (316). A mutation in END3 or SLA2 decreases the amount of Chs3 in purified chitosomes (315, 316). The interaction between Chs3 and Skt5 at the plasma membrane is required for CSIII activity (65, 209, 283). Finally, the appearance and activity of Chs3 at the bud neck depend on the association of the Chs3 activator Skt5 with Bni4, a protein recruited by the Cdc10 septin (65). This data set is consistent with Chs3 being transported through the secretory pathway, stored in chitosomes, and then mobilized to the plasma membrane in a Chs6- and septin-dependent process where it is fully activated upon interaction with Skt5 (Fig. 2B).
A chs3 mutant lacks chitin at the incipient bud site and in the lateral wall, with chitin detectable only at the septum (258). This indicates that Chs3 is responsible both for the synthesis of the chitin ring at the bud base and for lateral wall chitin. The chitin ring is thought to provide stretching resistance at the bud neck, thereby ensuring cell integrity during bud expansion (Fig. 2A and B [note the presence of the ring]). A chs2 chs3 double mutant is inviable, indicating that these two chitin synthases have partially redundant function. Indeed, in a chs2 mutant, Chs3 synthesizes a "remedial septum," which is disorganized and much thicker than the wild-type primary septum (258). Under conditions of cell wall stress, such as defective glucan synthesis or exposure to cell surface-perturbing agents, the levels of chitin in the cell wall increase dramatically in a Chs3-dependent manner (211, 221). Thus, Chs3 is a component of the normal cell wall synthesis machinery that can be stress activated (Fig. 2B). In addition, CHS3 mRNA is induced during sporulation, and the spore walls of homozygous chs3/chs3 null diploids lack chitosan (46, 215). Thus, the role of Chs3 during sporulation is to make the chitin which is deacetylated to chitosan during ascospore maturation (see below). Furthermore, CSIII activity can be stimulated by the sporulation-specific Skt5 homologue Shc1p, indicating a dedicated Chs3 activation pathway in ascospore synthesis (248).
The third CHS gene, CHS1, shows an expression pattern similar to that of CHS3, peaking in early G1, while the Chs1 level remains constant during the cell cycle (215, 315). Chs1 shows the same dual subcellular localization as Chs3, with most of the protein found in chitosomes and a minor fraction found at the plasma membrane (147, 315). Since Chs1 and Chs3 both populate chitosome vesicles, they are thought to follow the same route. However, the localization of Chs1 is independent of Chs6 (316), hinting that Chs1 may require specific trafficking factors.
A chs1 null mutant shows a cell wall defect at the birth scar, which can lead to daughter cell lysis (37). This phenotype is dependent on the chitinase-encoding gene CTS1 and is almost completely suppressed in a chs1 cts1 double mutant (38). These data led to a model in which Chs1 repairs the chitinase-mediated septum degradation that occurs during cell separation. CHS1 mRNA levels are induced by extracellular calcium in a Crz1-dependent process (309) and by mating pheromones (9, 46, 236). The CHS1 promoter contains pheromone-responsive elements. CSI is the only chitin synthase activity detectable in vitro from extracts of cells in stationary phase (29), but the biological significance of this finding remains unclear.
In addition to fungal cell walls, chitin is found in nematode eggshells and in insect and crustacean exoskeletons, and to date, the SwissProt (http://au.expasy.org/sprot/) and BRENDA (http://www.brenda.uni-koeln.de/) databases contain more than 50 sequences of chitin synthase genes. Since chitin is critical for development and morphogenesis, chitin synthesis inhibitors and chitinolytic enzymes have been developed as fungicides and insecticides.
Using Chs2 as a model, Nagahashi and colleagues mapped the catalytic domain of this chitin synthase, which contains three motifs (QXXEY, EDRXL, and QXRRW) that are found in all chitin synthases and believed to be necessary for the transfer of GlcNAc to the growing chitin chain (198). An alignment of amino acid sequences of 48 fungal chitin synthases extends the consensus sequence (QXXEYXnLPG/A, LA/GEDRXL, QR/GRRWL/IN) and reveals that this signature domain is included in a
250-amino-acid region with conserved predicted secondary structure (244). A second region located C terminal to a putative transmembrane domain is thought to play a role in chitin extrusion across the plasma membrane (306). Two families occur, based on the position of the chitin synthase signature domain, with family 1 and 2 proteins having their motifs in their middle or in their C-terminal half, respectively (244). S. cerevisiae Chs1 and Chs2 belong to family 1 and Chs3 to family 2. Chs1 shares 58% and 28% identity with Chs2 and Chs3, respectively, and Chs2 shares 32% identity with Chs3 over the signature domain. In addition to the position of the chitin synthase signature domain, the two families are distinguished by the presence of specific motifs. These chitin synthase families can be further subdivided in five classes (23, 181, 266), with families 1 and 2 containing three and two distinct classes, respectively.
Classes I and II, originating from family 1, are found in yeasts and filamentous fungi. Chs1 and Chs2 are found in classes I and II, respectively. The third family 1 class, class III, is found only in filamentous fungi. Family 2 enzymes of class IV are found in yeasts and filamentous fungi, whereas class V Chs proteins are found in filamentous fungi only. Class IV contains Chs3 and Chs3-like proteins. Interestingly, a number of class IV members, including Chs3, bear a C-terminal region whose deletion leads to a dramatic decrease in chitin synthase activity (58). This hydrophilic region, which is absent from Chs1- or Chs2-like proteins, may constitute a regulatory domain. Chs3 can self-interact in a two-hybrid test, showing that it can dimerize (65). Whether the protein functions as a dimer and whether other Chs proteins also dimerize remain to be demonstrated. Class V members are characterized by the presence of a large myosin motor-like domain which has a presumed role in the actin-based localization of these proteins to sites of active chitin synthesis during the cell wall growth of hyphal filaments.
Chitin deacetylases. Two sporulation-specific S. cerevisiae genes, CDA1 and CDA2, confer chitin deacetylase activity when ectopically expressed during vegetative growth and together are required for chitosan formation during sporulation (Table 1) (48, 185). An homozygous cda1/cda1 cda2/cda2 double mutant shows increased spore lysis upon treatment with the lytic enzyme preparation Zymolyase or Glusulase, indicating the protective role of the chitosan layer (48, 185).
Protein glycosylation and mannan synthesis.
Two types of oligosaccharidic protein modifications have been described for S. cerevisiae. N-glycosylated proteins receive an oligosaccharide through an N-glycosidic bond between a GlcNAc and an asparagine residue, while O-mannoslyated proteins receive short mannose chains onto the hydroxyl side chains of serine or threonine residues through an
-mannosyl bond (255). These processes have been extensively reviewed (60, 66, 270) and are covered in outline here.
(i) Protein N glycosylation.
All N-modified glycoproteins acquire the same initial oligosaccharide in the ER, and subsequently most intracellular glycoproteins are additionally modified, with the final chains, containing 9 to 13 mannose residues, being referred to as "core"-type oligosaccharides (60). In contrast, cell wall and secreted mannoproteins are extensively mannosylated in the Golgi, with a final structure of
-1,6-linked mannose chain of up to 50 mannose residues extending from the N-glycan core and to which are attached shorter chains of
-1,2 residues terminating in
-1,3-linked mannose residues, forming a highly branched structure containing as many as 200 mannose residues (14; see reference 60 for a review).
As a first step, the oligosaccharyl transferase complex transfers a Glc3Man9GlcNAc2 structure from a dolichyl-phosphate-linked precursor (see references 31 and 210 for reviews on precursor synthesis) onto an asparagine residue of N-X-S/T sequons, where X represents any amino acid residue except proline (reviewed in reference 66). Oligosaccharides are then trimmed in the ER by the action of glucosidases I and II and mannosidase I, encoded by CWH41, ROT2, and MNS1, respectively (see reference 109 for a review), leading to a Man8GlcNAc2 structure. This processing is part of a protein-folding quality control process that expedites protein export to the Golgi apparatus (see reference 79 for a review). Trimmed oligosaccharides are in some cases extended by the action of Golgi mannosyltransferases (Table 1).
Upon entry into the cis-Golgi of N-glycosylated proteins that are destined to be further elaborated, the Och1
-1,6-mannosyltransferase catalyzes the transfer of a mannose residue to the Man8GlcNAc2 structure (199, 200). Glycoproteins produced by a null och1 mutant lack
-1,6-polymannose, indicating that the addition of this initial mannose residue is critical for other reactions to take place and/or that Och1 is involved in the catalysis of subsequent
-1,6 linkages (199). OCH1 is important for cell wall function, as an och1 null mutant shows a slow- and temperature-sensitive-growth phenotype that can be rescued by sorbitol addition (148, 200).
Subsequently, an
-1,6-mannose backbone of up to 50 residues is synthesized by the action of two cis-Golgi mannose polymerase (ManPol) complexes (124, 125). A striking feature of these complexes is that all known proteins resemble mannosyltransferases, with ManPol I containing Van1 and Mnn9 and ManPol II containing Mnn10, Mnn11, Anp1, Hoc1, and Mnn9. Assays of these complexes indicate that both have
-1,6-mannosyltransferase activity that can be compromised when some individual genes are deleted (124, 125). Components of the ManPol I complex exhibit differential in vitro activities, with Van1 being an
-1,6-mannosyltransferase and Mnn9 showing dual
-1,2- and
-1,6-mannosyltransferase activity (269). The
-1,2-mannosyltransferase activity conferred by Mnn9 may also play a role in the "core"-type modification of intracellular glycoproteins (269).
The
-1,6-mannose backbone shows
-1,2 branched chains, added by the
-1,2-mannosyltransferase Mnn2. Branches are then extended by
-1,2-linked mannose residues by Mnn5, a close homologue of Mnn2 (234). Five additional related proteins also participate in outer-chain extension (107, 110): Kre2/Mnt1, an
-1,2-mannosyltransferase whose structure has recently been determined and mechanism of catalytic action proposed (159); Ktr1, a demonstrated
-1,2-mannosyltransferases (241); and Ktr2, Ktr3, and Yur1, which have been implicated as mannosyltransferases in vitro and in vivo (163). The outer chain can be further branched by the action of the mannosylphosphate transferase Ktr6/Mnn6, another Kre2-related protein (300). Together with the uncharacterized Ktr4, Ktr5, and Ktr7, the Kre2-related proteins form the KTR family (162). Whereas Ktr2, Ktr6, and Yur1 affect protein N glycosyl-ation, Kre2, Ktr1, and Ktr3 are involved in both protein N and O glycosylation (see below).
Finally, outer chains are terminated in the late Golgi by addition of an
-1,3-linked mannose by Mnn1. MNN1 with five additional genes forms a family consisting of two subfamilies (162). The first of these contains the
-1,2-mannosyltransferases Mnn2 and Mnn5, which are involved in protein N glycosylation and mentioned above. The second subfamily contains Mnn1, which are involved in both N and O glycosylation (see below), and Mnt2, Mnt3 and Mnt4, which are involved in protein O mannosylation (see below).
(ii) Protein O mannosylation.
O-linked oligosaccharides consist of short chains of up to five mannose units, with the first two residues being
-1,2 linked and subsequent ones
-1,3 linked. Despite the small size of the O-linked chains, many cell wall proteins have serine/threonine-rich domains, and so the number of O chains per protein can be high and the amount of O-linked mannose in the cell wall significant (reviewed in reference 270).
The initial step of O mannosylation occurs in the ER, where a single mannose residue is transferred from a dolichyl-phosphate-mannose precursor (see references 31 and 210 for reviews of precursor synthesis) onto serine/threonine residues by a family of seven protein-O-mannosyltransferases, the PMT family (see reference 270 for a review). Subsequent steps occur in the Golgi and are catalyzed by mannosyltransferases using GDP-mannose as the sugar donor (Table 1). Three KTR family members, Kre2/Mnt1, Ktr1, and Ktr3, have been shown to be involved in catalyzing the two
-1,2 links (see reference 162 for a review). The two terminal
-1,3 links are catalyzed by the MNN1 family members Mnn1, Mnt2, and Mnt3 (100, 242, 308).
As discussed below, mannoproteins can be linked in numerous ways with other cell wall polymers: in some cases, the polymannose structure is thought to form a direct link with ß-1,3-glucan chains, while some proteins are linked through a remnant of their GPI anchor and others appear to be directly linked to ß-1,3-glucan through their protein moiety.
GPI-cell wall proteins.
Cell wall digestion with laminarinase releases proteins that bind to anti-ß-1,6-glucan antibodies (130). Nuclear magnetic resonance analysis revealed that the protein-ß-1,6-glucan bond involves an ethanolamine-PO4-oligomannoside composed of four or five mannose residues, three of which are decorated with ethanolamine phosphate (83, 86, 117, 138). This structure is a GPI anchor remnant, indicating that GPI-modified proteins form a class of cell wall proteins (Fig. 1A). Acquisition of the GPI anchor occurs in the ER, where a preassembled anchor is transferred to the C terminus of target proteins (see reference 210 for a review). The GPI anchor is usually attached to an N/S/G/A/D/C residue found in the 40 C-terminal amino acids of the protein and in the context N/S/G/A/D/C-G/A/S/V/I/E/T/K/D/L/F-G/A/S/V-X4-19-
10 (where
represents a hydrophobic amino acid). The attachment reaction involves a proteolytic cleavage C terminal of the attachment residue and a transamidation between the generated amino acid and the ethanolamine phosphate of the GPI anchor (62, 210). A GPI anchorage signal can be found in
70 secretory proteins in the yeast genome (40, 62). Of these, about a third either are demonstrated CWPs or contain a signal sufficient to direct a fusion protein to the cell wall (105), a third are suspected to be CWPs based on sequence homology, and a third are known or putative plasma membrane proteins. So far, no cell wall-targeting signal has been described for GPI-CWPs, whereas an additional signal, usually a dibasic motif, seems to be required for the correct GPI anchoring in the plasma membrane, suggesting that the default destination for GPI-modified proteins is the cell wall (40, 62). In the ER, GPI-modified proteins are packaged in specialized COPII-coated vesicles for transport to the Golgi, where the N-and O-linked carbohydrate chains and the GPI anchor are extended and modified (272). A number of known GPI-proteins, including GPI-CWPs such as Ccw12, Ccw14, and Cwp2 have been shown to be extensively O mannosylated (187, 192, 290). Other GPI-CWPs contain serine/threonine-rich domains, which are sites of mannose attachment, suggesting that O mannosylation is a common feature of GPI-CWPs.
Based on amino acid sequence similarity, some GPI-CWPs can be grouped into families, including the flocculins, the agglutinins, and the CRH1-UTR2, the TIR, and the SED1-SPI1 families (40, 62). The flocculins, or Flo proteins, are lectin-like adhesion proteins with a role in flocculence and invasive growth (for a review, see reference 295). The critical role of the mating-type-specific agglutinins Aga1 and Sag1 in cell-cell adhesion prior to mating is well established (for a review, see reference 156). Crh1 and Utr2 are candidate cross-linking enzymes that are involved in cell wall remodeling during vegetative growth (see below). The TIR family contains 10 members which are differentially expressed depending upon growth conditions. Two TIR genes, CWP1 and CWP2, are expressed during vegetative growth. Singly, their deletion, as well as that of the TIR gene TIP1, confers hypersensitivity to calcofluor white and Congo red (290). When viewed by electron microscopy, a cwp2 null mutant has a thinner cell wall than a wild-type strain (290). CWP1 and CWP2 are repressed under anaerobiosis, whereas other TIR genes (DAN1, DAN4, TIP1, TIR1, TIR2, TIR3, and TIR4) and two additional genes encoding non-GPI but Tir-related proteins (DAN2 and DAN3) are induced and thus show differential responses to aerobic and anaerobic conditions (3). Supporting this hypothesis, tir1, tir3, and tir4 single null mutants all show growth defects when cultivated anaerobically (3). Transcription profiling and studies of sterol uptake suggest that Dan1, and maybe Dan3, Dan4, and Tir4, could play a role in sterol influx under anaerobic conditions by binding sterols in the cell wall (304). In a similar way, the Fit set of GPI-anchored cell wall mannoproteins assist in iron uptake (223). These proteins are encoded by the FIT1, FIT2, and FIT3 genes, whose expression is induced in an Aft1-dependent way upon iron deprivation. Though not directly involved in iron transport through the plasma membrane, these Fit proteins bind iron in the cell wall, and in their absence, there is reduced uptake of iron bound to the siderophores ferrioxamine B and ferrichrome. The iron bound to these cell wall proteins is thought to increase the concentration of iron at the cell surface and thus facilitate iron uptake into the cell. The binding of ergosterol and iron by cell wall proteins raises the possibility that other small-molecule nutrients may also be sequestered in this way. The fifth family includes SED1 and SPI1, two stress-responsive genes induced by glucose limitation (227, 259). These gene products have a protective role under starvation and stress conditions, with mutants being hypersensitive to oxidative stress or Zymolyase (82, 259, 262). A pair of GPI-CWPs which do not fall in these families are Ccw12 and Ccw14. Compared to a wild-type strain, ccw12 and ccw14 null mutants show hypersensitivity to calcofluor white and Congo red, and the ccw12
mutant has a reduced mating efficiency (192).
Collectively, the GPI-CWPs appear to have a general function in cell wall stability. The hypersensitivity to calcofluor white of a ccw12
mutant is partially suppressed in a ccw12 ccw14 mutant and completely rescued in a ccw12 ccw14 dan1 triple null mutant. Interestingly, the additional deletion of TIP1 or CWP1 in the ccw12 ccw14 dan1 triple mutant had no additional effect on the calcofluor white sensitivity. This suggests that a compensation process is triggered when a defect threshold is reached. The CCW12 deletion alone may not be sufficient to trigger this compensatory process, and it probably involves the two stress GPI-CWPs Sed1 and Spi1, since ccw12 ccw14 dan1 sed1 and ccw12 ccw14 dan1 spi1 quadruple null mutants both show calcofluor white hypersensitivity (104). In another study, a ccw12 ccw14 cwp1 dan1 tip1 quintuple mutant showed an elevated mortality in stationary phase (276).
The PIR family and mild-alkali-extractable cell wall proteins. (i) The PIR family. Treatment of biotinylated cell wall extracts with mild alkali results in the release of six proteins (194), with the four most abundant being Pir1/Ccw6, Hsp150/Pir2/Ccw7, Pir3/Ccw8, and Cis3/Pir4/Ccw5. These Pir proteins (for proteins with internal repeats) are structurally related, are serine/threonine rich, and are thought to be extensively O mannosylated (94, 194). They consist of a putative N-terminal signal peptide, followed by a Kex2 endoprotease cleavage site, an internal repeat region, and a C-terminal cysteine-based motif (194, 279). In a kex2 mutant, a shift in electrophoretic mobility of the Pir proteins was observed. However, their relative abundance was unchanged compared to that in the wild type. Thus, the Kex2 cleavage site is used in vivo but is not required for cell wall localization, leaving a role for this processing event open (194).
Pir1, Hsp150, and Pir3 can be detected with an anti-Pir3 antibody and visualized in the lateral wall of wild-type cells by immunoelectron microscopy (310). In contrast, a specific anti-Cis3 antibody localized Cis3 exclusively in the growing buds of vegetative cells (188). The nature of the links between the Pir proteins and the cell wall is unclear (Fig. 1A). The presence of Pir proteins linked to ß-1,3-glucan that are releasable by mild alkali treatment suggests that a glycosidic bond links the ß-1,3-glucan and a mannose residue of the O-linked chains of the Pir proteins (136). The internal repeats are probably involved in connecting Pir proteins to ß-1,3-glucan, as suggested by a CIS3 mutational analysis (43). To date, neither the identity of nor the enzyme catalyzing the Pir protein-ß-1,3-glucan link are known. Hsp150 and Cis3 were also found among the proteins released upon treatment of the cell wall with ß-mercaptoethanol or dithiothreitol, showing that they are linked to other CWPs through disulfide bonds (Fig. 1A), probably involving the cysteine-rich C terminus (39, 43, 189).
The PIR genes show cell-cycle-dependent expression, with levels of the CIS3 transcript peaking in G2 and those of the PIR1, HSP150, and PIR3 transcripts peaking in early G1 (267). The levels of the four PIR mRNAs are elevated in a constitutively active mkk1 mutant in an Rlm1-dependent manner, indicating that their expression is under PKC cell integrity pathway control (123). This is consistent with the finding that these genes belong to a group of cell wall perturbation-responsive genes, with their expression being stimulated by exposure to calcofluor white or Zymolyase (22). Furthermore, PIR1, HSP150, and PIR3 are induced by high temperature (310). Apart from a hypersensitivity phenotype to aluminum-mediated oxidative stress seen in an hsp150
mutant (82), no effects on growth rate, cell morphology, or viability were found in mutants singly deleted for any of the PIR genes (195, 279). However, a pir1 hsp150 double null mutant shows reduced growth on solid medium and hypersensitivity to heat shock (279). A cis3 pir1 hsp150 triple null mutant shows hypersensitivity to calcofluor white and Congo red (195), and a pir1 hsp150 pir3 triple null mutant is hypersensitive to tobacco osmotin and shows an elevated mortality phenotype during stationary phase (204, 276, 310). Finally, a quadruple pir mutant shows a sorbitol-suppressible increased mortality both during exponential growth and in stationary phase (276). These data suggest a protective role for the Pir proteins, for example, as barrier proteins influencing cell wall permeability.
(ii) Other cell wall proteins with alkali-sensitive links. The proteins released from isolated cell walls treated with sodium dodecyl sulfate and then HF or NaOH were identified using mass spectrometry (307). The set of proteins released by HF treatment, which cleaves phosphodiester bonds, contains known GPI-CWPs such as Ccw14 and Cwp1 as well as Pry3, a protein whose GPI anchor signal can target a fusion protein to the cell wall (105). In addition, other GPI-modified proteins such as GAS family members, the glucosidases Crh1 and Utr2 (see below), and the phospholipase Plb2 were also found. In addition to the Pir proteins, the set of NaOH-released proteins includes Cwp1, the putative glucanases Scw4 and Scw10, and the agglutinin-related Tos1. This work suggests that a GPI-CWP can be linked to the cell wall through either its GPI remnant or its oligosaccharide chains. The finding of several glucanases covalently linked to the cell wall implies that they function in remodeling the glucan matrix.
Roles of cell wall mannoproteins. O-linked mannose chains are short and rigid, and by cross-linking proteins to the ß-1,3-glucan, they may play a role in cell wall strengthening. In addition, mannoproteins usually show extensive N-linked glycosylation. The roles of fungal covalently linked cell wall proteins in processes such as water retention, adhesion, and virulence have been reviewed (63). Many of these functions require proper glycosylation of the respective proteins. Mutations of the synthetic glycosylation and mannosylation pathways collectively affect all mannoproteins and cause multiple cell wall phenotypes, such as compound or stress hypersensitivity and altered cell wall composition (63, 210). However, some steps in protein glycosylation are catalyzed by gene families whose members' substrate specificity can directly affect cell wall assembly. For example, the PMT family members Pmt4p and the Pmt1-Pmt2 pair act in vitro on Gas1 and Pir2, respectively (270). In addition, high redundancy occurs within families of Golgi mannosyltransferases, with most single mutants showing weak or no phenotypes. However, the impact of these gene families on cell wall synthesis is seen by the severe cell wall phenotypes found in triple or quadruple mutants (8, 162). The proliferation of genes and gene products with overlapping function in Golgi N and/or O mannosylation suggests that such gene duplications have conferred fitness and have been selected for during fungal evolution.
(i) GAS1 and the GAS gene family. The following observations implicate GAS1 in cell wall synthesis: (i) a mutation in GAS1/CWH52 confers hypersensitivity to calcofluor white and to caspofungin (150, 233), (ii) a gas1 mutant shows decreased ß-1,3-glucan levels and increased mannan and chitin contents in its cell wall (231), and (iii) a gas1 mutant secretes high levels of ß-1,3-glucan (232). The last observation implies that the ß-1,3-glucan chains made in a gas1 mutant are abnormally assembled. An in vitro assay for transglucosidase activity using recombinant enzyme shows that Gas1 can catalyze the formation of a ß-1,3-glycosidic bond between the reducing end of a donor ß-1,3-glucan chain and the nonreducing end of a acceptor ß-1,3-glucan molecule (42, 190). These data point toward Gas1 acting in vivo as a ß-1,3-glucan elongase.
Gas1 is synthesized as a 559-residue precursor, with a cleavable N-terminal signal peptide. During its transit through the ER, Gas1 is N and O glycosylated and receives a C-terminal GPI anchor (92, 207, 208, 287). The ER-modified Gas1, likely along with other GPI-modified proteins, is packaged into specialized COPII secretory vesicles and transported from the ER to the Golgi, where the N- and O-linked glycans are further elaborated (196, 272). Mature Gas1 is a 115-kDa protein, anchored in the outer leaflet of the plasma membrane (for a review, see reference 222). This localization is consistent with the presumed role of Gas1 in cell wall remodeling. The Gas1 GPI anchor is required for function, since expression of a tailless Gas1 fails to complement a gas1
mutant (222). Gas1 was recently identified in cell walls after sodium dodecyl sulfate treatment, suggesting that a fraction of Gas1 is cov